Nonmelanoma skin cancer in inflammatory bowel disease: a review.

Published

Journal Article (Review)

At least 1 million new cases of nonmelanoma skin cancer (NMSC) are diagnosed in the United States each year and the incidence is increasing. A higher incidence of NMSC in organ transplant recipients on immunosuppression has been documented for some time, and recent studies indicate that patients with inflammatory bowel disease (IBD), particularly those treated with immunosuppressive medications, might also be at higher risk for this condition. In this review we summarize recent data evaluating the associations between immunomodulators, antitumor necrosis factor-α biologic agents and NMSC in patients with IBD and other autoimmune conditions such as rheumatoid arthritis. We also offer recommendations for prevention of NMSC in these populations.

Full Text

Duke Authors

Cited Authors

  • Long, MD; Kappelman, MD; Pipkin, CA

Published Date

  • June 2011

Published In

Volume / Issue

  • 17 / 6

Start / End Page

  • 1423 - 1427

PubMed ID

  • 21053358

Pubmed Central ID

  • 21053358

Electronic International Standard Serial Number (EISSN)

  • 1536-4844

International Standard Serial Number (ISSN)

  • 1078-0998

Digital Object Identifier (DOI)

  • 10.1002/ibd.21484

Language

  • eng